Loading…

Mechanisms by which oxidative injury inhibits the proliferative response of human lymphocytes to PHA. Effect of the thiol compound 2-mercaptoethanol

The use of normobaric exposure to O2 as a model for in vitro oxidative injury prevented phytohaemagglutinin (PHA)-stimulated human peripheral blood mononuclear cells (PBMC) from undergoing the G0 to G1 transition, but 5 x 10(-6) M 2-mercaptoethanol (2-ME) almost protected the cells from this blockad...

Full description

Saved in:
Bibliographic Details
Published in:Immunology 1988-06, Vol.64 (2), p.281-288
Main Authors: Gougerot-Pocidalo, M A, Fay, M, Roche, Y, Chollet-Martin, S
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 288
container_issue 2
container_start_page 281
container_title Immunology
container_volume 64
creator Gougerot-Pocidalo, M A
Fay, M
Roche, Y
Chollet-Martin, S
description The use of normobaric exposure to O2 as a model for in vitro oxidative injury prevented phytohaemagglutinin (PHA)-stimulated human peripheral blood mononuclear cells (PBMC) from undergoing the G0 to G1 transition, but 5 x 10(-6) M 2-mercaptoethanol (2-ME) almost protected the cells from this blockade. The percentage of cells with IL-2 and transferrin-receptors was reduced by the O2 exposure and, like the cell cycle transition, was protected by 2-ME against oxidative injury. By contrast, IL-2 recovery in the supernatants of O2-exposed PHA-stimulated PBMC was enhanced. This enhancement may be due partly to the reduced IL-2 consumption caused by the decreases in IL-2 receptor expression and in proliferation. On the other hand, IL-2 recovery in the supernatants of O2-treated PBMC was always enhanced compared to the IL-2 control recovery after DNA synthesis was blocked in G1/S by mitomycin c, and the G0/G1 transition was protected by 2-ME. Furthermore, PHA-stimulated monocytes exposed to O2 produced more IL-1 than control cells. This enhanced IL-1 production was not modified by 2-ME. These results suggest that oxidative injury reduces the proliferation of PBMC by interfering with the cellular events that lead to the transition from the G0 to the G1 phase of the cell cycle. The protective effects of 2-ME suggest that thiol compounds have a critical role in the early events of the cell cycle. By contrast, exposure to O2 induced increases in the production of both IL-1 and IL-2 that may not be related to alterations in the thiol status of the cell.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1384955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14994586</sourcerecordid><originalsourceid>FETCH-LOGICAL-p292t-95fa37dccd42fa885bce04ba9e02bedf782ec64ecf3af00ebb4cb435e4d462ca3</originalsourceid><addsrcrecordid>eNqFkctKxTAURYsoen18gpCRs0qaR9tMBBFfoOhAxyVJT0ykbWqSqv0PP9iKF9GRo83mLBYbzka2KmjJc8LLajNbYVyInNSY72S7MT4vlWLOt7NtSkVRMrrKPm5BWzm42EekZvRmnbbIv7tWJvcKyA3PU5iXsE65FFGygMbgO2cgfBMB4uiHCMgbZKdeDqib-9F6PSdYeI_ur06P0bkxoNMX82VI1vkOad-PfhpaRPIegpZj8pCWLb7bz7aM7CIcrHMve7w4fzi7ym_uLq_PTm_ykQiScsGNpFWrdcuIkXXNlQbMlBSAiYLWVDUBXTLQhkqDMSjFtGKUA2tZSbSke9nJt3ecVA-thiEF2TVjcL0Mc-Ola_5eBmebJ__aFLRmgvNFcLQWBP8yQUxN76KGrpMD-Ck2VU1xKerqX7BgQjBelwt4-HvSz5b1w-gn3t-ZNw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14994586</pqid></control><display><type>article</type><title>Mechanisms by which oxidative injury inhibits the proliferative response of human lymphocytes to PHA. Effect of the thiol compound 2-mercaptoethanol</title><source>PubMed Central</source><creator>Gougerot-Pocidalo, M A ; Fay, M ; Roche, Y ; Chollet-Martin, S</creator><creatorcontrib>Gougerot-Pocidalo, M A ; Fay, M ; Roche, Y ; Chollet-Martin, S</creatorcontrib><description>The use of normobaric exposure to O2 as a model for in vitro oxidative injury prevented phytohaemagglutinin (PHA)-stimulated human peripheral blood mononuclear cells (PBMC) from undergoing the G0 to G1 transition, but 5 x 10(-6) M 2-mercaptoethanol (2-ME) almost protected the cells from this blockade. The percentage of cells with IL-2 and transferrin-receptors was reduced by the O2 exposure and, like the cell cycle transition, was protected by 2-ME against oxidative injury. By contrast, IL-2 recovery in the supernatants of O2-exposed PHA-stimulated PBMC was enhanced. This enhancement may be due partly to the reduced IL-2 consumption caused by the decreases in IL-2 receptor expression and in proliferation. On the other hand, IL-2 recovery in the supernatants of O2-treated PBMC was always enhanced compared to the IL-2 control recovery after DNA synthesis was blocked in G1/S by mitomycin c, and the G0/G1 transition was protected by 2-ME. Furthermore, PHA-stimulated monocytes exposed to O2 produced more IL-1 than control cells. This enhanced IL-1 production was not modified by 2-ME. These results suggest that oxidative injury reduces the proliferation of PBMC by interfering with the cellular events that lead to the transition from the G0 to the G1 phase of the cell cycle. The protective effects of 2-ME suggest that thiol compounds have a critical role in the early events of the cell cycle. By contrast, exposure to O2 induced increases in the production of both IL-1 and IL-2 that may not be related to alterations in the thiol status of the cell.</description><identifier>ISSN: 0019-2805</identifier><identifier>EISSN: 1365-2567</identifier><identifier>PMID: 3391643</identifier><language>eng</language><publisher>England</publisher><subject>Cell Cycle - drug effects ; Cell Division - drug effects ; Cells, Cultured ; Humans ; Immune Tolerance - drug effects ; Interleukins - biosynthesis ; Lymphocyte Activation - drug effects ; Lymphocytes - cytology ; Lymphocytes - immunology ; Mercaptoethanol - pharmacology ; Oxygen - antagonists &amp; inhibitors ; Oxygen - pharmacology ; Phytohemagglutinins - pharmacology</subject><ispartof>Immunology, 1988-06, Vol.64 (2), p.281-288</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1384955/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1384955/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3391643$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gougerot-Pocidalo, M A</creatorcontrib><creatorcontrib>Fay, M</creatorcontrib><creatorcontrib>Roche, Y</creatorcontrib><creatorcontrib>Chollet-Martin, S</creatorcontrib><title>Mechanisms by which oxidative injury inhibits the proliferative response of human lymphocytes to PHA. Effect of the thiol compound 2-mercaptoethanol</title><title>Immunology</title><addtitle>Immunology</addtitle><description>The use of normobaric exposure to O2 as a model for in vitro oxidative injury prevented phytohaemagglutinin (PHA)-stimulated human peripheral blood mononuclear cells (PBMC) from undergoing the G0 to G1 transition, but 5 x 10(-6) M 2-mercaptoethanol (2-ME) almost protected the cells from this blockade. The percentage of cells with IL-2 and transferrin-receptors was reduced by the O2 exposure and, like the cell cycle transition, was protected by 2-ME against oxidative injury. By contrast, IL-2 recovery in the supernatants of O2-exposed PHA-stimulated PBMC was enhanced. This enhancement may be due partly to the reduced IL-2 consumption caused by the decreases in IL-2 receptor expression and in proliferation. On the other hand, IL-2 recovery in the supernatants of O2-treated PBMC was always enhanced compared to the IL-2 control recovery after DNA synthesis was blocked in G1/S by mitomycin c, and the G0/G1 transition was protected by 2-ME. Furthermore, PHA-stimulated monocytes exposed to O2 produced more IL-1 than control cells. This enhanced IL-1 production was not modified by 2-ME. These results suggest that oxidative injury reduces the proliferation of PBMC by interfering with the cellular events that lead to the transition from the G0 to the G1 phase of the cell cycle. The protective effects of 2-ME suggest that thiol compounds have a critical role in the early events of the cell cycle. By contrast, exposure to O2 induced increases in the production of both IL-1 and IL-2 that may not be related to alterations in the thiol status of the cell.</description><subject>Cell Cycle - drug effects</subject><subject>Cell Division - drug effects</subject><subject>Cells, Cultured</subject><subject>Humans</subject><subject>Immune Tolerance - drug effects</subject><subject>Interleukins - biosynthesis</subject><subject>Lymphocyte Activation - drug effects</subject><subject>Lymphocytes - cytology</subject><subject>Lymphocytes - immunology</subject><subject>Mercaptoethanol - pharmacology</subject><subject>Oxygen - antagonists &amp; inhibitors</subject><subject>Oxygen - pharmacology</subject><subject>Phytohemagglutinins - pharmacology</subject><issn>0019-2805</issn><issn>1365-2567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><recordid>eNqFkctKxTAURYsoen18gpCRs0qaR9tMBBFfoOhAxyVJT0ykbWqSqv0PP9iKF9GRo83mLBYbzka2KmjJc8LLajNbYVyInNSY72S7MT4vlWLOt7NtSkVRMrrKPm5BWzm42EekZvRmnbbIv7tWJvcKyA3PU5iXsE65FFGygMbgO2cgfBMB4uiHCMgbZKdeDqib-9F6PSdYeI_ur06P0bkxoNMX82VI1vkOad-PfhpaRPIegpZj8pCWLb7bz7aM7CIcrHMve7w4fzi7ym_uLq_PTm_ykQiScsGNpFWrdcuIkXXNlQbMlBSAiYLWVDUBXTLQhkqDMSjFtGKUA2tZSbSke9nJt3ecVA-thiEF2TVjcL0Mc-Ola_5eBmebJ__aFLRmgvNFcLQWBP8yQUxN76KGrpMD-Ck2VU1xKerqX7BgQjBelwt4-HvSz5b1w-gn3t-ZNw</recordid><startdate>19880601</startdate><enddate>19880601</enddate><creator>Gougerot-Pocidalo, M A</creator><creator>Fay, M</creator><creator>Roche, Y</creator><creator>Chollet-Martin, S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19880601</creationdate><title>Mechanisms by which oxidative injury inhibits the proliferative response of human lymphocytes to PHA. Effect of the thiol compound 2-mercaptoethanol</title><author>Gougerot-Pocidalo, M A ; Fay, M ; Roche, Y ; Chollet-Martin, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p292t-95fa37dccd42fa885bce04ba9e02bedf782ec64ecf3af00ebb4cb435e4d462ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Cell Cycle - drug effects</topic><topic>Cell Division - drug effects</topic><topic>Cells, Cultured</topic><topic>Humans</topic><topic>Immune Tolerance - drug effects</topic><topic>Interleukins - biosynthesis</topic><topic>Lymphocyte Activation - drug effects</topic><topic>Lymphocytes - cytology</topic><topic>Lymphocytes - immunology</topic><topic>Mercaptoethanol - pharmacology</topic><topic>Oxygen - antagonists &amp; inhibitors</topic><topic>Oxygen - pharmacology</topic><topic>Phytohemagglutinins - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gougerot-Pocidalo, M A</creatorcontrib><creatorcontrib>Fay, M</creatorcontrib><creatorcontrib>Roche, Y</creatorcontrib><creatorcontrib>Chollet-Martin, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gougerot-Pocidalo, M A</au><au>Fay, M</au><au>Roche, Y</au><au>Chollet-Martin, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanisms by which oxidative injury inhibits the proliferative response of human lymphocytes to PHA. Effect of the thiol compound 2-mercaptoethanol</atitle><jtitle>Immunology</jtitle><addtitle>Immunology</addtitle><date>1988-06-01</date><risdate>1988</risdate><volume>64</volume><issue>2</issue><spage>281</spage><epage>288</epage><pages>281-288</pages><issn>0019-2805</issn><eissn>1365-2567</eissn><abstract>The use of normobaric exposure to O2 as a model for in vitro oxidative injury prevented phytohaemagglutinin (PHA)-stimulated human peripheral blood mononuclear cells (PBMC) from undergoing the G0 to G1 transition, but 5 x 10(-6) M 2-mercaptoethanol (2-ME) almost protected the cells from this blockade. The percentage of cells with IL-2 and transferrin-receptors was reduced by the O2 exposure and, like the cell cycle transition, was protected by 2-ME against oxidative injury. By contrast, IL-2 recovery in the supernatants of O2-exposed PHA-stimulated PBMC was enhanced. This enhancement may be due partly to the reduced IL-2 consumption caused by the decreases in IL-2 receptor expression and in proliferation. On the other hand, IL-2 recovery in the supernatants of O2-treated PBMC was always enhanced compared to the IL-2 control recovery after DNA synthesis was blocked in G1/S by mitomycin c, and the G0/G1 transition was protected by 2-ME. Furthermore, PHA-stimulated monocytes exposed to O2 produced more IL-1 than control cells. This enhanced IL-1 production was not modified by 2-ME. These results suggest that oxidative injury reduces the proliferation of PBMC by interfering with the cellular events that lead to the transition from the G0 to the G1 phase of the cell cycle. The protective effects of 2-ME suggest that thiol compounds have a critical role in the early events of the cell cycle. By contrast, exposure to O2 induced increases in the production of both IL-1 and IL-2 that may not be related to alterations in the thiol status of the cell.</abstract><cop>England</cop><pmid>3391643</pmid><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0019-2805
ispartof Immunology, 1988-06, Vol.64 (2), p.281-288
issn 0019-2805
1365-2567
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1384955
source PubMed Central
subjects Cell Cycle - drug effects
Cell Division - drug effects
Cells, Cultured
Humans
Immune Tolerance - drug effects
Interleukins - biosynthesis
Lymphocyte Activation - drug effects
Lymphocytes - cytology
Lymphocytes - immunology
Mercaptoethanol - pharmacology
Oxygen - antagonists & inhibitors
Oxygen - pharmacology
Phytohemagglutinins - pharmacology
title Mechanisms by which oxidative injury inhibits the proliferative response of human lymphocytes to PHA. Effect of the thiol compound 2-mercaptoethanol
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T08%3A26%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanisms%20by%20which%20oxidative%20injury%20inhibits%20the%20proliferative%20response%20of%20human%20lymphocytes%20to%20PHA.%20Effect%20of%20the%20thiol%20compound%202-mercaptoethanol&rft.jtitle=Immunology&rft.au=Gougerot-Pocidalo,%20M%20A&rft.date=1988-06-01&rft.volume=64&rft.issue=2&rft.spage=281&rft.epage=288&rft.pages=281-288&rft.issn=0019-2805&rft.eissn=1365-2567&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E14994586%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p292t-95fa37dccd42fa885bce04ba9e02bedf782ec64ecf3af00ebb4cb435e4d462ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=14994586&rft_id=info:pmid/3391643&rfr_iscdi=true